Dataset Information

TEAD inhibitor K-975 enhances KRASG12C inhibitor adagrasib-mediated cancer cell proliferation inhibition via dual cell cycle arrest

ABSTRACT: Here we investigate the effect of the dual inhibition, in KRASG12C mutated NSCLC cells, using the KRASG12Ci adagrasib (MRTX849) and the pan-TEAD inhibitor (TEADi) K-975. We show that K-975 enhances adagrasib-induced tumor cell growth inhibition in cancer cells. Mechanistically, we detect a downregulation of MYC and E2F signatures and a downregulation of the G2/M checkpoint regulation, which result in the increase of G1 and the decrease of the G2/M cell cycle phases. These data suggest that the co-inhibition of KRASG12C and YAP1-TEAD leads to a specific switch in the mechanism of cancer cell killing.

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Iris Valtingojer

PROVIDER: PXD039726 | JPOST Repository | Fri May 12 00:00:00 BST 2023

REPOSITORIES: jPOST

ACCESS DATA

Publications

TEAD Inhibitors Sensitize KRASG12C Inhibitors via Dual Cell Cycle Arrest in KRASG12C-Mutant NSCLC.

Tammaccaro Salvina Laura SL Prigent Philippe P Le Bail Jean-Christophe JC Dos-Santos Odette O Dassencourt Laurent L Eskandar Myriam M Buzy Armelle A Venier Olivier O Guillemot Jean-Claude JC Veeranagouda Yaligara Y Didier Michel M Spanakis Emmanuel E Kanno Tokuwa T Cesaroni Matteo M Mathieu Stephane S Canard Luc L Casse Alhassan A Windenberger Fanny F Calvet Loreley L Noblet Laurence L Sidhu Sukhvinder S Debussche Laurent L Moll Jurgen J Valtingojer Iris I

Pharmaceuticals (Basel, Switzerland) 20230406 4

KRASG12C is one of the most common mutations detected in non-small cell lung cancer (NSCLC) patients, and it is a marker of poor prognosis. The first FDA-approved KRASG12C inhibitors, sotorasib and adagrasib, have been an enormous breakthrough for patients with KRASG12C mutant NSCLC; however, resistance to therapy is emerging. The transcriptional coactivators YAP1/TAZ and the family of transcription factors TEAD1-4 are the downstream effectors of the Hippo pathwa ...[more]

PMID: 37111311

Dataset Information

TEAD inhibitor K-975 enhances KRASG12C inhibitor adagrasib-mediated cancer cell proliferation inhibition via dual cell cycle arrest

Publications

TEAD Inhibitors Sensitize KRAS<sup>G12C</sup> Inhibitors via Dual Cell Cycle Arrest in KRAS<sup>G12C</sup>-Mutant NSCLC.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Similar Datasets

Cell cycle-dependent gene networks for cell proliferation activated by nuclear CK2 complexes
2023-10-22 | PXD040882 | JPOST Repository

Oncogenic signals prime cancer cells for toxic cell growth during a G1 cell cycle arrest
2023-11-17 | PXD043792 | Pride

CDK4/6 inhibitors induce repication stress to cause long-term cell cycle withdrawal
2021-12-20 | PXD023435 | Pride

CDK4/6 inhibitor-mediated cell overgrowth triggers an osmotic stress response
2023-11-27 | PXD036519 | Pride

BET Protein Inhibitor JQ1 Induces Cell Cycle Arrest in Mesenchymal Stem Cells
2016-02-12 | E-GEOD-70577 | biostudies-arrayexpress

Cell cycle-dependent gene networks for cell proliferation activated by nuclear CK2 complexes [array]
2023-10-19 | GSE227739 | GEO

BET Protein Inhibitor JQ1 Induces Cell Cycle Arrest in Mesenchymal Stem Cells
2016-02-12 | GSE70577 | GEO

The OTUD6B-LIN28B-MYC axis determines cell cycle progression in multiple myeloma
2022-10-12 | PXD027480 | Pride

Histone PTM profiling during the cell cycle
2019-09-09 | PXD013288 | Pride